Articles tagged with 'Vascular Intervention' | BIOTRONIK

BIOTRONIK - Archive (Vascular Intervention)

2021
27
September
2021
| 11:03 Europe/Amsterdam
 BIOTRONIK is proud to announce the enrollment of the first patient in the BIONETIC-I study of the safety and efficacy of the Dynetic®-35 cobalt chromium balloon-expandable stent system for the treatment of atherosclerotic peripheral artery disease l...
Read more
23
September
2021
| 08:53 Europe/Amsterdam
BIOTRONIK is proud to announce the completion of enrollment of the investigator-initiated BIOPACT randomized controlled trial (RCT). This non-inferiority study evaluates the safety and efficacy of paclitaxel drug-coated balloons (DCBs), comparing the...
Read more
15
September
2021
| 09:28 Europe/Amsterdam
BIOTRONIK is pleased to announce the expansion of the Fortress® reinforced introducer sheath line, which is now available in 7- and 8F-compatible sizes in the United States and countries that recognize European CE Mark approval.  The Fortress introdu...
Read more
15
March
2021
| 14:42 Europe/Amsterdam
BIOTRONIK’s ultrathin-strut stent, Orsiro®*, demonstrated superiority over Xience DES for target lesion failure (TLF) at 24 months, according to new follow-up data from the BIOSTEMI trial.1The latest results were presented by Prof. Thomas Pilgrim, In...
Read more